[Beta-receptor blockers after revascularization in coronary sclerosis].
Osterziel
K J
KJ
Abteilung Kardiologie, Angiologie und Pulmonologie Franz-Volhard-Klinik Berlin-Buch, Virchow-Klinikum der Humboldt-Universität.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D011433:Propranolol / Q000627:therapeutic use; D012008:Recurrence; D013997:Time Factors; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D013999:Timolol; D011433:Propranolol; D008790:Metoprolol
beta-Rezeptorenblocker nach Revaskularisation bei Koronarsklerose.